Cardiex Limited (CDX:ASX)


right-arrow Created with Sketch. 0.001 (1.45%)
MCAP $64.82M
Last trade 15.40pm 30/07/2021 20mins delayed

Latest Announcements

26/07/2021 Price SensitivePSCDXCardiex Limited
23/07/2021CDXCardiex Limited
22/06/2021 Price SensitivePSCDXCardiex Limited
18/06/2021CDXCardiex Limited
18/06/2021CDXCardiex Limited
17/06/2021CDXCardiex Limited
11/06/2021CDXCardiex Limited
17/05/2021 Price SensitivePSCDXCardiex Limited

Company Overview

Cardiex Ltd, formerly AtCor Medical Holdings Ltd, is engaged in the designing, manufacturing and marketing of medical devices for use in cardiovascular management. The Company operates through three segments: Americas, which includes global pharmaceutical trials business; Europe, which includes Middle East and Africa, and Asia Pacific, which includes Asia and Australia/New Zealand. The Company's clinical trial services, include study protocol assistance, study-specific user manual, operator training and certification, study-specific training materials, automated data transfer for expert over-read, quality assurance, ongoing data management, technical support and sponsor-defined data transfers. The Company also offers SphygmoCor technology, which is used in clinical trials for a range of therapeutic areas, including hypertension, renal disease, heart failure, inflammatory processes, diabetes and chronic obstructive pulmonary disease (COPD).

CDX in the news

Search Previous Announcements